Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole once daily versus twice daily after Roux-en-Y gastric bypass
TCTR20261102006Phase 3Not yet recruiting
- Sponsor
- self pay
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole in anastomotic ulcer, sponsored by self pay. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
omeprazole
03
Conditions
anastomotic ulcer
Beyond the preview
Go deeper on TCTR20261102006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261102006.